Chemomab Therapeutics Ltd. - CMMB
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 01, 2026 | — | A | A | 5,172.0 | 0.0 | 0.0 | 18,075.0 | View | |
| Sep 01, 2026 | — | A | A | 3,821.0 | 0.0 | 0.0 | 12,903.0 | View | |
| Sep 01, 2026 | — | A | A | 2,520.0 | 0.0 | 0.0 | 9,082.0 | View | |
| Sep 01, 2026 | — | A | A | 1,714.0 | 0.0 | 0.0 | 6,562.0 | View | |
| Sep 01, 2026 | — | A | A | 1,705.0 | 0.0 | 0.0 | 4,848.0 | View | |
| Sep 01, 2026 | — | A | A | 2,971.0 | 0.0 | 0.0 | 3,143.0 | View | |
| Sep 01, 2026 | — | A | A | 172.0 | 0.0 | 0.0 | 172.0 | View | |
| Sep 01, 2026 | — | S | D | 1,000.0 | 2.8 | 2,800.0 | 33,000.0 | View | |
| Sep 01, 2026 | — | S | D | 1,304.0 | 2.85 | 3,716.4 | 34,000.0 | View | |
| Jun 01, 2026 | Chief Executive Officer | J | D | 18,750.0 | — | — | 18,750.0 | View | |
| Jun 01, 2026 | Chief Executive Officer | J | D | 31,712.0 | — | — | 31,712.0 | View | |
| Jun 01, 2026 | Chief Executive Officer | P | D | 4,926.0 | 2.08 | 10,246.08 | 139,131.0 | View | |
| Jun 01, 2026 | Chief Executive Officer | P | D | 4,878.0 | 2.05 | 9,999.9 | 134,205.0 | View |